891 related items for PubMed ID: 33352473
1. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
Koch T, Doherty DA, Dickinson JE, Juul A, Hart R, Bräuner EV, Hickey M.
Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
[Abstract] [Full Text] [Related]
2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society (AES).
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[Abstract] [Full Text] [Related]
3. The association between in utero exposure to maternal psychological stress and female reproductive function in adolescence: A prospective cohort study.
Bräuner EV, Koch T, Doherty DA, Dickinson JE, Juul A, Hart R, Hickey M.
Compr Psychoneuroendocrinol; 2021 Feb; 5():100026. PubMed ID: 35754448
[Abstract] [Full Text] [Related]
4. The association between in-utero exposure to stressful life events during pregnancy and male reproductive function in a cohort of 20-year-old offspring: The Raine Study.
Bräuner EV, Hansen ÅM, Doherty DA, Dickinson JE, Handelsman DJ, Hickey M, Skakkebæk NE, Juul A, Hart R.
Hum Reprod; 2019 Jul 08; 34(7):1345-1355. PubMed ID: 31143949
[Abstract] [Full Text] [Related]
5. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study.
Hickey M, Sloboda DM, Atkinson HC, Doherty DA, Franks S, Norman RJ, Newnham JP, Hart R.
J Clin Endocrinol Metab; 2009 Oct 08; 94(10):3714-20. PubMed ID: 19567524
[Abstract] [Full Text] [Related]
6. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
Skiba MA, Bell RJ, Herbert D, Garcia AM, Islam RM, Davis SR.
Hum Reprod; 2021 May 17; 36(6):1611-1620. PubMed ID: 33846715
[Abstract] [Full Text] [Related]
7. Prenatal exposure to maternal stressful life events and earlier age at menarche: the Raine Study.
Bräuner EV, Koch T, Juul A, Doherty DA, Hart R, Hickey M.
Hum Reprod; 2021 Jun 18; 36(7):1959-1969. PubMed ID: 33744952
[Abstract] [Full Text] [Related]
8. Effect of the presence of polycystic ovary syndrome-related features on anti-Mullerian hormone and androstenedione levels in adolescents with or without menstrual irregularity.
Hanedan N, Ersoy B, Hanedan C, Ozyurt BC, Taneli F.
Arch Gynecol Obstet; 2022 Aug 18; 306(2):523-531. PubMed ID: 35355114
[Abstract] [Full Text] [Related]
9. The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.
Vural F, Vural B, Kardaş E, Ertürk Coşkun AD, Yildirim İ.
Arch Gynecol Obstet; 2023 Apr 18; 307(4):1083-1090. PubMed ID: 36565362
[Abstract] [Full Text] [Related]
10. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis.
Hickey M, Doherty DA, Atkinson H, Sloboda DM, Franks S, Norman RJ, Hart R.
Hum Reprod; 2011 Jun 18; 26(6):1469-77. PubMed ID: 21478180
[Abstract] [Full Text] [Related]
11. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents.
Villarroel C, López P, Merino PM, Iñiguez G, Sir-Petermann T, Codner E.
Gynecol Endocrinol; 2015 Jun 18; 31(8):625-9. PubMed ID: 26190534
[Abstract] [Full Text] [Related]
12. Sex-dependent associations between maternal prenatal stressful life events, BMI trajectories and obesity risk in offspring: The Raine Study.
Bräuner EV, Lim YH, Koch T, Mori TA, Beilin L, Doherty DA, Juul A, Hart R, Hickey M.
Compr Psychoneuroendocrinol; 2021 Aug 18; 7():100066. PubMed ID: 35757055
[Abstract] [Full Text] [Related]
13. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
West S, Lashen H, Bloigu A, Franks S, Puukka K, Ruokonen A, Järvelin MR, Tapanainen JS, Morin-Papunen L.
Hum Reprod; 2014 Oct 10; 29(10):2339-51. PubMed ID: 25085801
[Abstract] [Full Text] [Related]
14. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
Bell RJ, Islam RM, Skiba MA, Herbert D, Martinez Garcia A, Davis SR.
Hum Reprod; 2021 Dec 27; 37(1):109-118. PubMed ID: 34741176
[Abstract] [Full Text] [Related]
15. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
[Abstract] [Full Text] [Related]
16. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
Adams JM, Taylor AE, Crowley WF, Hall JE.
J Clin Endocrinol Metab; 2004 Sep 01; 89(9):4343-50. PubMed ID: 15356031
[Abstract] [Full Text] [Related]
17. New Diagnostic Criteria of Polycystic Ovarian Morphology for Adolescents: Impact on Prevalence and Hormonal Profile.
Merino PM, Villarroel C, Jesam C, López P, Codner E.
Horm Res Paediatr; 2017 Sep 01; 88(6):401-407. PubMed ID: 29049986
[Abstract] [Full Text] [Related]
18. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
Pasquali R, Zanotti L, Fanelli F, Mezzullo M, Fazzini A, Morselli Labate AM, Repaci A, Ribichini D, Gambineri A.
J Clin Endocrinol Metab; 2016 May 01; 101(5):2013-22. PubMed ID: 26964728
[Abstract] [Full Text] [Related]
19. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D.
Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589
[Abstract] [Full Text] [Related]
20. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D, Alebić MŠ, Duhamel A, Stojanović N.
Hum Reprod; 2014 Nov 01; 29(11):2536-43. PubMed ID: 25267785
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
